Can Taking Creatine Raise Your PSA Levels?

No study has directly shown that creatine supplementation raises prostate-specific antigen levels. The concern stems from an indirect chain of reasoning: creatine might increase dihydrotestosterone (DHT), DHT is an androgen, and PSA production is androgen-driven. Each link in that chain has some scientific basis, but the chain as a whole has never been tested end to end, and the hormonal evidence itself is more conflicting than most gym-floor conversations suggest. Meanwhile, a factor far more likely to muddy your PSA results is the very activity creatine is meant to support.

Where the Worry Comes From

PSA is a protein produced almost exclusively by the prostate gland, and its production is switched on by androgens. The gene that encodes PSA contains specific binding sites for the androgen receptor, which means testosterone and its more potent derivative DHT directly control how much PSA the prostate makes.¹ In simple terms, when androgen levels go up, PSA tends to follow. This is the reason men on testosterone replacement therapy sometimes see their PSA climb, and why drugs that block androgens (like finasteride) push PSA down.

Against that background, a small 2009 study in college-aged rugby players drew attention because it reported that creatine loading raised DHT by about 56% after seven days, and DHT remained roughly 40% above baseline after two more weeks on a maintenance dose. The ratio of DHT to testosterone also climbed.² If that finding held up broadly, the logic would be straightforward: more DHT means more androgen signaling in the prostate, which means more PSA in the blood. That study, however, did not measure PSA, so the final step in the reasoning was never confirmed.

The DHT Evidence Is Not Settled

The rugby-player study has been cited widely, but it was a single trial with a small number of participants. A longer and more recent randomized controlled trial, lasting twelve weeks with both a creatine group and a placebo group, found no significant changes in DHT, testosterone, or the DHT-to-testosterone ratio between the two groups.³ That trial was designed specifically to look at hormonal and hair-related outcomes, and it turned up nothing on either front.

So the first link in the chain, creatine raises DHT, has one positive result and at least one well-controlled negative result. The honest reading is that the hormonal effect, if it exists at all, is inconsistent across study populations and dosing protocols. Even the original rugby study noted that testosterone itself did not change, only the conversion ratio. Whether a transient shift in conversion during a loading phase would be enough to measurably push PSA higher in a healthy man has simply not been tested.

Serum Creatinine, Prostate Cancer, and PSA

A related but distinct question involves serum creatinine, the waste product your kidneys filter out after your muscles use creatine. One large prospective study found that men who later developed prostate cancer had slightly higher pre-diagnostic serum creatinine levels, and the highest creatinine quartile was associated with roughly double the odds of prostate cancer compared with the lowest quartile. But the same study measured both creatinine and PSA in a subset of participants and found essentially zero correlation between the two. The statistical relationship was as close to nothing as you can get.⁴

This is an important distinction. Higher serum creatinine might be a marker of something metabolically relevant to prostate cancer risk, but it does not appear to raise PSA itself. Since creatine supplementation does increase serum creatinine modestly (your muscles have more creatine to break down), some men worry that their elevated creatinine on a blood panel implies prostate trouble. The evidence says that link does not run through PSA.

The Confounder That Actually Does Raise PSA

If you take creatine, you probably exercise, and exercise is a well-documented cause of short-term PSA spikes. A study measuring PSA before and after just fifteen minutes on a stationary bike found that PSA concentrations jumped by as much as threefold immediately afterward.⁵ Cycling is a particularly potent trigger because of direct pressure on the perineum, but vigorous resistance training, running, and other high-intensity activity also cause elevations.

The practical takeaway is that the exercise surrounding creatine use poses a bigger risk to your PSA reading than the creatine itself. If you do heavy squats or ride a bike the morning before a PSA blood draw, that alone can push your result into a range your doctor considers abnormal. Most clinical guidelines recommend avoiding strenuous exercise for at least 24 to 48 hours before PSA testing, and some sources advise avoiding cycling for a full week. If you’re a regular creatine user heading in for a PSA test, the timing of your last workout matters far more than whether you took your creatine that day.

Creatine Kinase Inside the Prostate

The prostate gland itself uses creatine kinase, the enzyme that recycles creatine phosphate for quick energy. Prostate tissue contains almost exclusively the BB isoform of this enzyme, regardless of whether the tissue is healthy, enlarged (benign hyperplasia), or cancerous.⁶ That means the prostate has its own local creatine energy system, which understandably raises the question of whether flooding the body with supplemental creatine affects the prostate directly.

Recent cancer biology research adds an interesting twist. The creatine kinase B enzyme (CKB) in prostate cells appears to have a tumor-suppressive role: overexpressing CKB slowed cancer cell migration and tumor growth in lab models, while silencing it promoted cancer progression. Low CKB expression was also linked to worse outcomes in prostate cancer patients.⁷ None of this tells us what oral creatine supplementation does to CKB activity in human prostate tissue, and jumping from cell-culture experiments to supplement recommendations is a stretch. But the finding is worth noting because it cuts against the assumption that anything creatine-related is automatically bad for the prostate. The biology is more complicated than the worry implies.

When Your PSA Is in the Gray Zone

Most of the anxiety around PSA involves readings in the so-called gray zone, roughly between 4 and 10 ng/mL, where both benign prostate enlargement and early cancer can produce similar numbers. If you’re a creatine user who lands in that range and your doctor orders follow-up tests, understanding what those tests measure can save you unnecessary stress or, conversely, prevent false reassurance.

One of the most useful refinements is the ratio of free PSA to total PSA. PSA circulates in the blood in two forms: bound to other proteins or floating free. Cancer tends to produce more of the bound form, so a lower percentage of free PSA raises suspicion. A large multicenter trial found that free PSA percentage was significantly better at distinguishing cancer from benign disease than total PSA alone in men with total PSA between 4 and 10 ng/mL. Using a cutoff of 25% free PSA could have spared about one in five men an unnecessary biopsy without missing cancers.⁸ The complexed PSA-to-total PSA ratio provides similar discrimination.⁹

Newer risk-prediction tools combine total PSA with the free-to-total ratio in nomograms that estimate a man’s individual probability of having high-grade versus low-grade cancer. One such model showed about 80% accuracy in identifying clinically significant disease.¹⁰ The point is that a single total PSA number, particularly one in the gray zone, tells you surprisingly little on its own. If creatine, exercise, benign enlargement, or any other factor nudges your total PSA up a fraction, the free-to-total ratio and other follow-up tools exist precisely to sort signal from noise.

Creatine in Men Already Being Treated for Prostate Cancer

A separate but related question is whether creatine supplementation is safe for men who already have prostate cancer, especially those on androgen deprivation therapy (ADT). ADT shuts down testosterone production, which is the main medical lever for controlling PSA and slowing disease. Introducing a supplement that might fiddle with androgen pathways sounds risky in that context.

A double-blind randomized trial tested this directly. Men with prostate cancer on ADT were assigned to either creatine or placebo alongside a resistance-training program. Both groups improved muscle mass, strength, and physical function in similar amounts, and creatine did not add any extra benefit over the placebo. Critically, the trial did not report safety concerns related to PSA or disease progression in the creatine group.¹¹ That does not mean creatine is universally safe for men on ADT, but it does mean that the one trial designed to test this did not find the feared hormonal interference.

Men on ADT often face significant muscle loss and fatigue, which is why resistance training is increasingly recommended as supportive care. Creatine is a logical candidate supplement in that population, and the fact that researchers felt comfortable testing it in a clinical trial suggests the theoretical DHT concern was not strong enough to prevent the study from being approved on ethical grounds. The results were underwhelming in terms of added benefit, but at least reassuring in terms of safety.

What to Do Before a PSA Test

If you use creatine and have a PSA test scheduled, the evidence points to a few practical steps. First, avoid intense exercise for at least 48 hours before the blood draw. The three-fold spike documented after cycling alone should make the case.⁵ If you ride a bike regularly, a longer window of avoidance is reasonable. Second, tell your doctor you take creatine. Not because there’s proven evidence it raises PSA, but because your doctor should know about anything that could affect your lab work, and the serum creatinine elevation from supplementation often triggers its own set of questions about kidney function.

Third, if your PSA comes back mildly elevated, resist the urge to blame or absolve creatine. Ask your doctor about the free PSA percentage and whether a repeat test after a rest period makes sense. Many mildly elevated PSA readings in active men normalize once the exercise variable is removed. A second reading taken after a few days of rest and no vigorous activity is far more informative than a single number drawn after leg day.

Supplements, Lab Work, and the Limits of Inference

Creatine is one of the most studied sports supplements in existence, and the research on its safety profile is genuinely reassuring across kidney function, hydration, muscle cramping, and most other commonly raised concerns. But “most studied” does not mean “studied for every possible endpoint.” PSA is a niche biomarker that matters to a specific population, mainly men over forty and those with a family history of prostate cancer. The supplement industry’s research priorities naturally skew younger and more athletic, so the overlap between creatine studies and PSA outcomes is thin.

The androgen pathway remains the most plausible theoretical route by which creatine could influence PSA. PSA transcription is regulated by androgen response elements that bind the androgen receptor, and DHT is a far more potent activator of that receptor than testosterone.¹² So the mechanism by which creatine could theoretically raise PSA, through increased DHT, is biologically coherent. The problem is that the triggering step, the DHT rise from creatine, has not been reliably reproduced. One study found it; a more recent and longer one did not.³ Without a consistent trigger, the downstream worry about PSA remains speculative.

Until a study directly measures PSA in men taking creatine versus placebo over a meaningful period, the honest answer is that we don’t know for certain, but the available evidence leans against a clinically significant effect. The far more actionable factor for anyone concerned about accurate PSA testing is managing the timing of exercise before their blood draw.